GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international pharmaceutical and laboratory equipment supplier, closed the first half of 2016 with significant double-digit gains in sales revenue and earnings1.
"We showed excellent performance in both divisions and all regions," said Group CEO Dr. Joachim Kreuzburg, who raised the full-year targets upon publication of the first-half figures. .
"We showed excellent performance in both divisions and all regions," said Group CEO Dr. Joachim Kreuzburg, who raised the full-year targets upon publication of the first-half figures. .
